{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:51:40Z","timestamp":1782143500394,"version":"3.54.5"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006084","name":"Office of AIDS Research","doi-asserted-by":"publisher","award":["5R24TW008863"],"award-info":[{"award-number":["5R24TW008863"]}],"id":[{"id":"10.13039\/100006084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0215807","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T17:39:11Z","timestamp":1556213951000},"page":"e0215807","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-5836","authenticated-orcid":true,"given":"Nnabuike Chibuoke","family":"Ngene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagidesa","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thajasvarie","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0143-4004(80)80012-9","article-title":"Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy","volume":"1","author":"R Pijnenborg","year":"1980","journal-title":"Placenta"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"JM Roberts","year":"2009","journal-title":"Placenta"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"SE Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"ref4","article-title":"Global Pregnancy Collaboration. Global Pregnancy Collaboration symposium: Prepregnancy and very early pregnancy antecedents of adverse pregnancy outcomes: Overview and recommendations","author":"JM Roberts","year":"2017","journal-title":"Placenta"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.preghy.2012.06.003","article-title":"Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia","volume":"2","author":"Z Liu","year":"2012","journal-title":"Pregnancy Hypertens"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"JM Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0002-9378(88)80169-8","article-title":"Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.","volume":"159","author":"GM Rodgers","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","article-title":"Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study","volume":"71","author":"S Agrawal","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.114.03578","article-title":"Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study","volume":"64","author":"LC Kenny","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1038\/s41598-017-06178-z","article-title":"Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles","volume":"7","author":"M O'Brien","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"e6005","DOI":"10.1097\/MD.0000000000006005","article-title":"Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes","volume":"96","author":"A Lea\u00f1os-Miranda","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajog.2004.11.038","article-title":"Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia","volume":"193","author":"RW Powers","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"6966","key":"ref13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/bmj.309.6966.1395","article-title":"Eclampsia in the United Kingdom.","volume":"309","author":"K Douglas","year":"1994","journal-title":"BMJ"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/10641950500543897","article-title":"A review of the management of eclampsia: practical issues","volume":"25","author":"J Moodley","year":"2006","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1373\/clinchem.2014.230565","article-title":"Preeclampsia: an old disease with new tools for better diagnosis and risk management","volume":"61","author":"M Abou El Hassan","year":"2015","journal-title":"Clin Chem"},{"issue":"1263\u20131272","key":"ref16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","article-title":"Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates","volume":"67","author":"A Makris","year":"2016","journal-title":"Hypertension"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1080\/14767058.2017.1404569","article-title":"Physiology of blood pressure relevant to managing hypertension in pregnancy","volume":"32","author":"NC Ngene","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"653.e1","DOI":"10.1016\/j.ajog.2008.06.030","article-title":"Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies","volume":"199","author":"R Troisi","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"18","key":"ref19","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/CIRCULATIONAHA.115.015721","article-title":"Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period","volume":"132","author":"A Goel","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"359.e1","DOI":"10.1016\/j.ajog.2016.04.002","article-title":"Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors","volume":"215","author":"J Yang","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ijgo.12424","article-title":"Role of angiogenic factors in the pathogenesis and management of pre-eclampsia","volume":"14","author":"NC Ngene","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"020401","DOI":"10.7189\/jogh.08.020401","article-title":"Maternal and perinatal adverse outcomes in women with pre-eclampsia cared for at facility-level in South Africa: a prospective cohort study","volume":"8","author":"HL Nathan","year":"2018","journal-title":"J Glob Health"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7196\/SAMJ.2018.v108i10.13280","article-title":"Spontaneous liver haematoma rupture associated with pre-eclampsia in a low- to middle-income country: Lessons to be learnt from maternal death assessments","volume":"108","author":"J Moodley","year":"2018","journal-title":"S Afr Med J"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"E Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10641955.2016.1193190","article-title":"Hypertensive disorders in primigravid black South African women: A one-year descriptive analysis","volume":"35","author":"J Moodley","year":"2016","journal-title":"Hypertens Pregnancy"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/jp.2016.247","article-title":"Is use of multiple antihypertensive agents to achieve blood pressure control associated with adverse pregnancy outcomes?","volume":"37","author":"SE Allen","year":"2017","journal-title":"J Perinatol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7196\/sajog.1033","article-title":"Avoidable factors associated with pregnant and postpartum patients admitted to two intensive care units in South Africa.","volume":"22","author":"N Ngene","year":"2016","journal-title":"S Afr J Obstet Gynaecol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia.","volume":"202","author":"S Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/uog.15850","article-title":"Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia.","volume":"47","author":"D Wright","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/HYPERTENSIONAHA.117.10150","article-title":"Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review","volume":"70","author":"UV Ukah","year":"2017","journal-title":"Hypertension"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis &amp; management recommendations for international practice","volume":"13","author":"M Brown","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"ref32","unstructured":"National Collaborating Centre for Women\u2019s and Children\u2019s Health. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy 2011. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nice.org.uk\/guidance\/cg107\/evidence\/cg107-hypertension-in-pregnancy-full-guideline3\" xlink:type=\"simple\">https:\/\/www.nice.org.uk\/guidance\/cg107\/evidence\/cg107-hypertension-in-pregnancy-full-guideline3<\/ext-link> (accessed 7 January 2019)."},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajo.12399","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"S Lowe","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref34","unstructured":"National Institute for Health and Clinical Excellence. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE clinical guideline 107 2010. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nice.org.uk\/guidance\/cg107\/resources\/hypertension-in-pregnancy-diagnosis-and-management-35109334009285\" xlink:type=\"simple\">https:\/\/www.nice.org.uk\/guidance\/cg107\/resources\/hypertension-in-pregnancy-diagnosis-and-management-35109334009285<\/ext-link> (accessed 31 December 2016)."},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000003018","article-title":"Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1701-2163(15)30588-0","article-title":"Clinical Practice Guidelines. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary. No. 307.","volume":"36","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","article-title":"The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP).","volume":"3","author":"AL Tranquilli","year":"2013","journal-title":"Pregnancy Hypertens"},{"issue":"34","key":"ref38","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"V Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.preghy.2018.02.013","article-title":"Baseline check of blood pressure readings of an automated device in severe pre-eclampsia and healthy normotensive pregnancy","volume":"12","author":"NC Ngene","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5830\/CVJA-2014-062","article-title":"South African Hypertension Guideline 2014","volume":"25","author":"YK Seedat","year":"2014","journal-title":"Cardiovasc J Afr"},{"key":"ref41","unstructured":"Roche Diagnostics GmbH. Elecsys sFlt-1 Immunoassay, Package Insert (ms_05109523190.V9.en). Sandhofer Strasse 116, D-68305 Mannheim, Germany 2018."},{"key":"ref42","unstructured":"Roche Diagnostics GmbH. Elecsys PlGF Immunoassay, Package Insert (ms_05144671190.V10.en). Sandhofer Strasse 116, D-68305 Mannheim, Germany 2018."},{"key":"ref43","unstructured":"National Department of Health Republic of South Africa. Guidelines for maternity care in South Africa: A manual for clinics, community health centres and district hospitals 2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.health-e.org.za\/wp-content\/uploads\/2015\/11\/Maternal-Care-Guidelines-2015_FINAL-21.7.15.pdf\" xlink:type=\"simple\">https:\/\/www.health-e.org.za\/wp-content\/uploads\/2015\/11\/Maternal-Care-Guidelines-2015_FINAL-21.7.15.pdf<\/ext-link> (accessed 14 July 2018)."},{"issue":"4","key":"ref44","first-page":"137","article-title":"Preeclampsia: an update","volume":"65","author":"G Lambert","year":"2014","journal-title":"Acta Anaesthesiol Belg"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/AOG.0000000000002019","article-title":". Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.","volume":"129","year":"2017","journal-title":"Obstet Gynaecol"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7196\/SAMJ.2016.v106i8.10908","article-title":"Severe hypertension in pregnancy: using dynamic checklist to save lives","volume":"106","author":"J Moodley","year":"2016","journal-title":"S Afr Med J"},{"issue":"12","key":"ref47","first-page":"1","article-title":"Estimating the Area under a Receiver Operating Characteristic Curve For Repeated Measures Design","volume":"8","author":"H Liu","year":"2003","journal-title":"J Stat Softw"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5812\/ijem.3505","article-title":"Normality Tests for Statistical Analysis: A Guide for Non-Statisticians.","volume":"10","author":"A Ghasemi","year":"2012","journal-title":"Int J Endocrinol Metab"},{"key":"ref49","author":"B Barton","year":"2014"},{"key":"ref50","unstructured":"Russell J. The Statistics tutor&apos;s quick guide to commonly used statistical tests. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.statstutor.ac.uk\/resources\/uploaded\/tutorsquickguidetostatistics.pdf\" xlink:type=\"simple\">http:\/\/www.statstutor.ac.uk\/resources\/uploaded\/tutorsquickguidetostatistics.pdf<\/ext-link> (accessed 28 February 2018)."},{"key":"ref51","article-title":"SPSS survival manual: A step by step guide to data analysis using SPSS","author":"J Pallant","year":"2011"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jpepsy\/jst062","article-title":"A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: we are ready to ROC","volume":"39","author":"EA Youngstrom","year":"2014","journal-title":"J Pediatr Psychol"},{"issue":"9","key":"ref53","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"JN Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-60543-2","article-title":"Introduction to statistical methods in pathology","author":"A Momeni","year":"2018"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"WJ Youden","year":"1950","journal-title":"Cancer"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/JTO.0b013e3181dab122","article-title":"Simple statistical measures for diagnostic accuracy assessment","volume":"5","author":"JN Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"JF Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"ref58","unstructured":"EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.equator-network.org\/reporting-guidelines\/\" xlink:type=\"simple\">https:\/\/www.equator-network.org\/reporting-guidelines\/<\/ext-link> (accessed 13 May 2018)."},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"e0188845","DOI":"10.1371\/journal.pone.0188845","article-title":"Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction\u2014implications for treating preeclampsia","volume":"13","author":"TJ Kaitu'u-Lino","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1471-0528.15042","article-title":"Angiogenic factors: potential to change clinical practice in pre-eclampsia?","volume":"125","author":"AS Cerdeira","year":"2018","journal-title":"BJOG"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5830\/CVJA-2012-003","article-title":"The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.","volume":"23","author":"L Govender","year":"2012","journal-title":"Cardiovasc J Afr"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7196\/sajog.1411","article-title":"Consensus statement on the potential implementation of the sFlt-1\/PlGF ratio in women with suspected pre-eclampsia","volume":"24","author":"M Matjila","year":"2018","journal-title":"S Afr Obstet Gynaecol"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"H Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref64","unstructured":"National Institute for Health and Care Excellence. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1\/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor\/BRAHMS PlGF plus Kryptor PE ratio). Diagnostics guidance 2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nice.org.uk\/guidance\/dg23\" xlink:type=\"simple\">www.nice.org.uk\/guidance\/dg23<\/ext-link>. Assessed 6 September 2017."},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7196\/sajog.1411","article-title":"Consensus statement on the potential implementation of the sFlt-1\/PlGF ratio in women with suspected pre-eclampsia","volume":"24","author":"M Matjila","year":"2018","journal-title":"S Afr Obstet Gynaecol"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"H Zeisler","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.18203\/2320-1770.ijrcog20182333","article-title":"Early onset and late onset preeclampsia-maternal and perinatal outcomes in a rural teritiary health center.","volume":"7","author":"E Gomathy","year":"2018","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.preghy.2015.12.003","article-title":"An analysis of the differences between early and late preeclampsia with severe hypertension","volume":"6","author":"XL Li","year":"2016","journal-title":"Pregnancy Hypertens"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14767058.2019.1569621","article-title":"Postpartum blood pressure patterns in severe preeclampsia and normotensive pregnant women following abdominal deliveries: a cohort study.","volume":"30","author":"NC Ngene","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref70","first-page":"157","article-title":"Preeclampsia: Basic, Genomic, and Clinical. Comprehensive Gynecology and Obstetrics","author":"AC Staff","year":"2018"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.preghy.2017.11.004","article-title":"Indications for delivery in pre-eclampsia","volume":"11","author":"N Varnier","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preghy.2018.01.001","article-title":"An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.","volume":"11","author":"M Stolz","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"ref73","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.116.08547","article-title":"Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique.","volume":"69","author":"UV Ukah","year":"2017","journal-title":"Hypertension"},{"issue":"1\u20132","key":"ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2013.05.003","article-title":"If we know so much about preeclampsia, why haven&apos;t we cured the disease?","volume":"99","author":"JM Roberts","year":"2013","journal-title":"J Reprod Immunol"},{"issue":"2","key":"ref75","first-page":"9","article-title":"Association of hypokalemia and preeclampsia and correlation of levels of serum potassium to blood pressure severity in preeclampsia","volume":"42","author":"JMA Paulino-Morente","year":"2018","journal-title":"Philipp J Obstet Gynecol"},{"issue":"2","key":"ref76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.","volume":"32","author":"S Rana","year":"2013","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"ref77","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/HYPERTENSIONAHA.117.09256","article-title":"Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy","volume":"69","author":"S Verlohren","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"ref78","first-page":"35","article-title":"Blood pressure measurement and rapid acting antihypertesnsives for severe hypertension in pregnancy","volume":"26","author":"NC Ngene","year":"2016","journal-title":"Obstetrics and Gynaecology Forum"},{"issue":"6","key":"ref79","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajog.2011.09.002","article-title":"Etiology and management of postpartum hypertension-preeclampsia","volume":"206","author":"BM Sibai","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"ref80","first-page":"68","article-title":"Treatment of hypertension during pregnancy","volume":"11","author":"D Hall","year":"2014","journal-title":"SA Heart"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4102\/sajhivmed.v15i2.23","article-title":"Needlestick injury in a pregnant inpatient in an overcrowded hospital.","volume":"15","author":"N Ngene","year":"2014","journal-title":"South Afr J HIV Med"},{"issue":"11","key":"ref82","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7196\/SAMJ.2018.v108i11.13252","article-title":"Lost to follow-up: Challenges to conducting orthopaedic research in South Africa","volume":"108","author":"DHS Badenhorst","year":"2018","journal-title":"S Afr Med J"},{"issue":"5","key":"ref83","first-page":"31S","article-title":"Clinical Factors Associated With Lower Postpartum Follow-up Among Women With Severe Preeclampsia [75].","volume":"125","author":"M Limaye","year":"2015","journal-title":"Obstet Gynaecol"},{"issue":"7","key":"ref84","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/aogs.12877","article-title":"Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.","volume":"95","author":"LA Magee","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.preghy.2018.04.003","article-title":"The effect of low-dose aspirin on serum placental growth factor levels in a high-risk PREDO cohort.","volume":"13","author":"K Murtoniemi","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"ref86","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"MY Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"ref87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/14767058.2017.1373760","article-title":"Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)\/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin","volume":"32","author":"K Navaratnam","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"ref88","doi-asserted-by":"crossref","first-page":"e107644","DOI":"10.1371\/journal.pone.0107644","article-title":"In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia","volume":"9","author":"S Gangooly","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"ref89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gheart.2017.06.001","article-title":"Roadmap to Achieve 25% Hypertension Control in Africa by 2025","volume":"13","author":"A Dzudie","year":"2018","journal-title":"Glob Heart"},{"issue":"5","key":"ref90","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7196\/SAMJ.2018.v108i5.13329","article-title":"Perioperative evaluation of patients who are due to undergo surgery","volume":"108","author":"N Ntusi","year":"2018","journal-title":"S Afr Med J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0215807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T22:02:22Z","timestamp":1663365742000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215807"}},"subtitle":[],"editor":[{"given":"Stefan","family":"Gebhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":90,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0215807","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]}}}